However, cancer patients receiving treatment with EGFR inhibitors had lower death rates than cancer patients receiving immunotherapy, chemotherapy or surgery (Albiges et al, 2020; Dai et al, 2020), thus suggesting that EGFR inhibition has a protective effect against severe COVID-19 pathologies. Here, EGFR is linked to COVID-19.